Current Diabetes Technology: Striving for the Artificial Pancreas
AbstractDiabetes technology has continually evolved over the years to improve quality of life and ease of care for affected patients. Frequent blood glucose (BG) checks and multiple daily insulin injections have become standard of care in Type 1 diabetes (T1DM) management. Continuous glucose monitors (CGM) allow patients to observe and discern trends in their glycemic control. These devices improve quality of life for parents and caregivers with preset alerts for hypoglycemia. Insulin pumps have continued to improve and innovate since their emergence into the market. Hybrid closed-loop systems have harnessed the data gathered with CGM use to aid in basal insulin dosing and hypoglycemia prevention. As technology continues to progress, patients will likely have to enter less and less information into their pump system manually. In the future, we will likely see a system that requires no manual patient input and allows users to eat throughout the day without counting carbohydrates or entering in any blood sugars. As technology continues to advance, endocrinologists and diabetes providers need to stay current to better guide their patients in optimal use of emerging management tools. View Full-Text
Share & Cite This Article
Allen, N.; Gupta, A. Current Diabetes Technology: Striving for the Artificial Pancreas. Diagnostics 2019, 9, 31.
Allen N, Gupta A. Current Diabetes Technology: Striving for the Artificial Pancreas. Diagnostics. 2019; 9(1):31.Chicago/Turabian Style
Allen, Natalie; Gupta, Anshu. 2019. "Current Diabetes Technology: Striving for the Artificial Pancreas." Diagnostics 9, no. 1: 31.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.